Loading...
Thumbnail Image
Publication

Rationalized Computer-Aided Design of Matrix-Metalloprotease-Selective Prodrugs

Jain, M.
Harburn, J.J.
Gill, Jason H.
Falconer, Robert A.
Mooney, C.A.
Cobb, S.L.
Berry, David J.
Publication Date
2017-05-25
End of Embargo
Supervisor
Rights
(c) 2017 ACS. This document is the Accepted Manuscript version of a Published Work that appeared in final form in the Journal of Medicinal Chemistry. To access the final edited and published work see http://dx.doi.org/10.1021/acs.jmedchem.6b01472.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Additional title
Abstract
Matrix metalloproteinases (MMPs) are central to cancer development and metastasis. They are highly active in the tumor environment and absent or inactive in normal tissues; therefore they represent viable targets for cancer drug discovery. In this study we evaluated in silico docking to develop MMP-subtype-selective tumor-activated prodrugs. Proof of principle for this therapeutic approach was demonstrated in vitro against an aggressive human glioma model, with involvement of MMPs confirmed using pharmacological inhibition.
Version
Accepted manuscript
Citation
Jain M, Harburn JJ, Gill JH et al (2017) Rationalized Computer-Aided Design of Matrix- Metalloprotease-Selective Prodrugs. Journal of Medicinal Chemistry. 60(10): 4496-4502.
Link to publisher’s version
Link to published version
Type
Article
Qualification name
Notes